This provider's $7.5M in total Medicare payments ranks in the 99th percentile of Dermatology providers nationally.
Medicare payments to this provider grew 305% from 2014 to 2023.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 93% in 2020
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $138.91 | $83.40 | 1.67x | $55.51 | $332.5K | 6.1K | 4.6K |
| 2015 | $190.20 | $70.63 | 2.69x | $119.57 | $371.4K | 7.2K | 4.9K |
| 2016 | $186.25 | $73.95 | 2.52x | $112.30 | $508.3K | 8.4K | 5.5K |
| 2017 | $178.21 | $72.50 | 2.46x | $105.71 | $503.0K | 9.5K | 5.7K |
| 2018 | $185.65 | $72.01 | 2.58x | $113.64 | $397.5K | 9.0K | 5.3K |
| 2019 | $236.92 | $82.11 | 2.89x | $154.81 | $424.5K | 9.7K | 5.2K |
| 2020 | $207.58 | $77.97 | 2.66x | $129.61 | $821.4K | 12.5K | 4.6K |
| 2021 | $221.10 | $92.82 | 2.38x | $128.28 | $1.3M | 14.9K | 5.2K |
| 2022 | $193.55 | $79.66 | 2.43x | $113.89 | $1.5M | 16.2K | 5.4K |
| 2023 | $233.54 | $85.46 | 2.73x | $148.08 | $1.3M | 15.5K | 5.8K |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| 77280 | Management of radiation therapy simulation, simple | 8.3K | $1.8M | $212.16 | 2.26x |
| G6001 | Ultrasonic guidance for placement of radiation therapy fields | 8.6K | $1.1M | $126.09 | 1.96x |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | 19.4K | $1.0M | $53.18 | 2.45x |
| 17004 | Destruction of 15 or more skin growths | 4.0K | $435.9K | $109.05 | 2.35x |
| 17110 | Destruction of up to 14 skin growths | 3.8K | $292.1K | $77.14 | 2.53x |
| 77401 | Radiation treatment delivery, superficial | 8.1K | $241.7K | $29.99 | 2.27x |
| 17000 | Destruction of skin growth | 6.3K | $234.9K | $37.21 | 3.14x |
| 11100 | Biopsy of single growth of skin and/or tissue | 3.5K | $230.3K | $66.11 | 2.38x |
| 77427 | Radiation treatment management, 5 treatments | 1.5K | $220.6K | $148.27 | 2.15x |
| 96574 | Application of light and light-sensitive drugs following removal of premalignant thickened skin growth, per day | 1.1K | $211.7K | $191.93 | 2.44x |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | 2.6K | $186.8K | $71.02 | 2.58x |
| 11102 | Tangential biopsy of single skin lesion | 2.3K | $151.7K | $65.55 | 3.31x |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 581 | $149.2K | $256.78 | 1.57x |
| 99202 | New patient office or other outpatient visit, typically 20 minutes | 1.9K | $91.3K | $48.97 | 2.61x |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | 2.5K | $90.6K | $36.02 | 2.34x |
| 96567 | Application of light to aid destruction of premalignant and/or malignant skin growths, each session | 839 | $79.1K | $94.23 | 2.33x |
| 95117 | Injection of incremental dosages of allergen, 2 or more injections | 10.3K | $77.7K | $7.56 | 2.53x |
| 17111 | Destruction of 15 or more skin growths | 809 | $74.7K | $92.35 | 2.54x |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | 914 | $71.6K | $78.35 | 2.51x |
| 11642 | Removal of malignant growth (1.1 to 2.0 centimeters) of the face, ears, eyelids, nose, or lips | 347 | $47.7K | $137.52 | 3.15x |
This provider submits charges 2.35 times higher than what Medicare actually pays.
A markup ratio of 2.35x means for every $100 Medicare pays, this provider initially charges $235. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data